Key Developments and Emerging Changes Shaping the Neuro Immunoassay Market Landscape

The neuro immunoassay market is on the brink of significant expansion, driven by technological advances and growing demand in healthcare diagnostics. As research continues to evolve and new tools emerge, this sector is set to experience robust growth, offering new opportunities for innovation and improved patient outcomes. Below is a detailed overview of the market's size, key players, emerging trends, and segmentation.

Steady Growth Expected in the Neuro Immunoassay Market Size by 2030
The neuro immunoassay market is projected to reach a valuation of $4.28 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2%. This upward trend during the forecast period is supported by several factors including the increasing adoption of artificial intelligence (AI) for data analysis, heightened investment in biomarker discovery, and the rising use of personalized medicine and therapeutic monitoring. Additionally, expansions in high-throughput screening technologies and growing demand for automated, precise immunoassay systems are boosting market growth. Key trends driving this market include innovations that enhance assay sensitivity and specificity, AI-enabled data interpretation, advances in multiplexed and lab-on-a-chip immunoassay platforms, focused research on neuro biomarker identification, and the development of integrated automated neurodiagnostic tools.

Download a free sample of the neuro immunoassay market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30676&type=smp

Major Companies Leading the Neuro Immunoassay Market
Several prominent organizations shape the competitive landscape of the neuro immunoassay market. Leading players include Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., and Abbexa Ltd.

Significant Industry Move to Strengthen Neuroimmunology Research
In a strategic acquisition in May 2026, Sanofi, a France-based biopharmaceutical firm specializing in immunology, vaccines, and neuroscience, purchased Vigil Neuroscience Inc. for about $470 million. This move is intended to bolster Sanofi's early-stage neurology and neuroimmunology research. Vigil's oral TREM2 agonist candidate, VG 3927, which targets microglial immune pathways implicated in Alzheimer's disease, will be integrated into Sanofi's development pipeline. Vigil Neuroscience, headquartered in the US, focuses on developing innovative therapies for neurodegenerative disorders such as Alzheimer's disease, emphasizing immune-modulating mechanisms within the central nervous system.

View the full neuro immunoassay market report:
https://www.thebusinessresearchcompany.com/report/neuro-immunoassay-market-report

Emerging Trends Shaping the Neuro Immunoassay Market's Future
Leading companies are prioritizing the development of advanced neuro immunoassay solutions, particularly blood-based neurological biomarker assays, to enhance disease monitoring and improve prognostic accuracy for neurological conditions. These blood-based assays measure specific proteins like Neurofilament Light Chain (NfL) in serum or plasma to evaluate neuronal damage and disease progression.

For example, in June 2024, Siemens Healthineers, a German in vitro diagnostics company, obtained CE marking for its Neurofilament Light Chain blood test. This test is compatible with the Atellica IM Analyzer and ADVIA Centaur systems and helps predict neuronal injury risk in adults with relapsing multiple sclerosis. It complements clinical, imaging, and laboratory evaluations, and the CE approval ensures compliance with European In Vitro Diagnostic regulations, broadening access to standardized neuro immunoassay diagnostics across European laboratories.

Detailed Segmentation Overview of the Neuro Immunoassay Market
This report categorizes the neuro immunoassay market based on various segments including:

1) Product Type: Options, Futures, Swaps, Contracts For Difference (CFDs), Tokenized and Non-Fungible Token-Based Derivatives
2) Derivative Type: Non-Fungible Tokens (NFTs), Tokenized In-Game Assets, Synthetic Assets and Futures, Prediction Market Contracts
3) Trading Platform: Exchange-Traded Derivatives (ETD), Over-The-Counter (OTC), Decentralized Finance (DeFi)
4) Underlying Asset: Crypto Gaming Tokens, Esports Event Wagers, Gaming Company Equities, In-Game Cosmetics and Crossovers, NFTs and Digital Collectibles
5) End-User: Casual Gamers and Fans, Businesses and Content Creators

Further subcategories under these segments include:
- Options: Call Options, Put Options, Binary Options, Barrier Options, Exotic Options
- Futures: Commodity Futures, Index Futures, Currency Futures, Interest Rate Futures, Volatility Futures
- Swaps: Interest Rate Swaps, Commodity Swaps, Currency Swaps, Total Return Swaps, Volatility Swaps
- Contracts For Difference: Equity CFDs, Commodity CFDs, Index CFDs, Cryptocurrency CFDs, Foreign Exchange CFDs
- Tokenized or Non-Fungible Token-Based Derivatives: Tokenized Futures, Tokenized Options, Tokenized Swaps, NFT Collateralized Derivatives, NFT Fractional Ownership Derivatives

This comprehensive segmentation provides insights into the diverse components and evolving nature of the neuro immunoassay market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.